San Francisco, CA, United States
San Francisco, CA, United States
SEARCH FILTERS
Time filter
Source Type

Wheat allergy is the fifth most common cause of food allergy in children. The prevalence of clinically significant wheat allergy is overestimated in the population. Furthermore, wheat allergy is often confused with celiac disease, as the layman may not be aware of the differences are not know. Due to parent insecurity many children are placed under dietary restrictions, where wheat is replaced by spelt. It is therefore vital to perform a detailed diagnosis with subsequent food challenges. Dietary restriction in wheat allergy is solely limited to the elimination of wheat, primal forms and products that contain wheat. The clinical relevance should be reviewed every 1-2 years.


Diel R.,Hannover Medical School | Loaddenkemper R.,Helios Inc. | Nienhaus A.,Institution for Statutory Accident Insurance and Prevention
Chest | Year: 2010

Test accuracy of interferon-γ release assays (IGRAs) for diagnosing TB differs when using older or precommerrial tools and inconsistent diagnostic criteria. This metaanalysis critically appraises studies investigating sensitivity and specificity of the commercial T-Spol.TB and the QuantiFERON-TB Cold In-Tube Assay (QFT-IT) among definitely confirmed TB cases. We searched Medline, EMBASE, and Cochrane bibliographies of relevant articles. Sensitivities, specificities, and indeterminate rates were pooled using a fixed effect model. Sensitivity of the tuberculin skin test (TST) was evaluated in the context of IGRA studies. In addition, the rates of indeterminates of both IGRAs were assessed. The pooled sensitivity of TST was 70% (95% CI, 0.67-0.72) compared with 81% (95% CI, 0.78-0.83) for the QFT-IT and 88% (95% CI, 0.85-0.90) for the T-Spot.TB. Sensitivity increased to 84% (95%CI, 0.81-0.87) and 89% (95% CI, 0.86-0.91) for the QFT-IT and T-Spot.TB, respectively, when restricted to performance in developed countries. In contrast, specificity of the QFT-IT was 99% (95% CI, 0.98-1.00) vs 86% for the T-Spot.TB (95% CI, 0.81-0.90). The pooled rate of indeterminate results was low, 2.1% (95% CI, 0.02-0.023) for the QFT-IT and 3.8% (95% CI, 0.035-0.042) for the T-Spot.TB, increasing to 4.4% (95% CI, 0.039-0.05) and 6.1% (95% CI, 0.052-0.071), respectively, among immunosuppressed hosts. The newest commercial IGRAs are superior, in comparison with the TST, for detecting confirmed active TB disease, especially when performed in developed countries. © 2010 American College of Chest Physicians.


Patent
Helios Inc. and Alanod Aluminium Veredlung GmbH | Date: 2013-02-04

In a method of manufacturing TSSS and TISS coatings applied onto substrates of copper or aluminum, inorganic pigments are functionalized by aminosilane. The functionalized pibment are used for making paints, which after the coil-coating onto the substrate form the coatings. For the functionalization, the pigment is dispersed in a solution of an aminosilane in a solvent or a mixture of a solvent and a binder without an addition of a non-aminosilane dispersing agent with or without subsequent grinding and use of 0.05-30% of aminosilane on pigment. An aromatic, aliphatic, cycloaliphatic, ketone, ester, ether or alcohol compound or a mixture thereof can be used as the solvent. A silicone-polyester, polyurethane or fluoropolymer can be used as the binder.


Patent
Helios Inc. and Alanod Aluminium Veredlung GmbH | Date: 2010-05-21

The invention relates to TSSS and TISS coatings applied by coil-coating onto substrates of copper or aluminum. Inorganic pigments functionalized by aminosilane are used for making paints, which after the coil-coating onto the substrate form the coatings. For the functionalization the pigment is dispersed in a solution of an aminosilane in a solvent or a mixture of a solvent and a binder without an addition of a non-aminosilane dispersing agent with or without subsequent grinding and use of 0.05-30% of aminosilane on pigment. An aromatic, aliphatic, cycloaliphatic, ketone, ester, ether or alcohol compound or a mixture thereof can be used as the solvent. A silicone-polyester, polyurethane or fluoropolymer can be used as the binder.


Trademark
Helios Inc. | Date: 2012-01-11

Dietary and nutritional supplements containing vitamin C.


Trademark
Helios Inc. | Date: 2014-09-24

hair care products, namely, conditioners, hair care lotions, hair care preparations, hair conditioners, hair lotion, hair oils, hair rinses, hair shampoo, hair shampoos and conditioners.


Trademark
Helios Inc. | Date: 2014-04-17

Dietary and nutritional supplements.


Trademark
Helios Inc. | Date: 2015-09-04

Tire tubes for vehicles; Tires; Tires for land vehicles; Tires for vehicle wheel and Tires for vehicles.


Trademark
Helios Inc. | Date: 2012-02-21

Dental instruments, namely, dental lasers; Lasers for medical use.


Loading Helios Inc. collaborators
Loading Helios Inc. collaborators